Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
Tapia-Alveal, Olsen and Worgall develop a novel strategy for patient-specific multiple myeloma diagnostics platform using DNA aptamers. The high affinity DNA aptamers enabled detection of minimal residual disease (MRD) when conventional MRD methods assessed complete remission and are adaptable to mu...
Main Authors: | Claudia Tapia-Alveal, Timothy R. Olsen, Tilla S. Worgall |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-12-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-020-01515-x |
Similar Items
-
Minimal residual disease in multiple myeloma: current status
by: Hong Ding, et al.
Published: (2021-10-01) -
Minimal residual disease detection in multiple myeloma: methods and prognostic significance
by: Evangelos Terpos
Published: (2020-10-01) -
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future
by: Alejandro Medina-Herrera, et al.
Published: (2023-07-01) -
Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
by: Charalampos Charalampous, et al.
Published: (2022-01-01) -
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2020-07-01)